X-Seal EU Post-Market Clinical Follow-Up Protocol

Femoral Arteriotomy Closure Clinical Trial

Official title:
X-Seal 6F Vascular Closure Device EU Post-Market Clinical Follow-Up Protocol

Status Completed

Clinical Trial Summary

The study is designed to prospectively collect data on and confirm the safety and effectiveness of the X-Seal 6F Vascular Closure System in reducing time to hemostasis and time to ambulation for patients who have undergone diagnostic or interventional catheterization procedures using up to 6F sheaths when compared with standard compression techniques using data from literature surveys.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Femoral Arteriotomy Closure

Clinical Trial Details

NCT number	NCT02406612
Study type	Interventional
Source	Essential Medical, Inc.
Contact
Status	Completed
Phase	N/A
Start date	April 2015
Completion date	June 2016

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05936996` - Prospective Clinical Registry Evaluating Contemporary MANTA Outcomes
Not yet recruiting	`NCT06358157` - The Ladera Large Bore Closure Feasibility Study	N/A
Completed	`NCT02521948` - Clinical Study to Evaluate the Safety and Performance of MANTA Vascular Closure Device	N/A
Completed	`NCT03330002` - MANTA Registry for Vascular Large-bore Closure
Completed	`NCT02908880` - MANTA Percutaneous Vascular Closure Device - The SAFE MANTA Study	N/A
Terminated	`NCT05142566` - MANTA Ultrasound Closure Study	N/A